Literature DB >> 25766847

Emerging concepts in the therapy of mitochondrial disease.

Carlo Viscomi1, Emanuela Bottani2, Massimo Zeviani3.   

Abstract

Mitochondrial disorders are an important group of genetic conditions characterized by impaired oxidative phosphorylation. Mitochondrial disorders come with an impressive variability of symptoms, organ involvement, and clinical course, which considerably impact the quality of life and quite often shorten the lifespan expectancy. Although the last 20 years have witnessed an exponential increase in understanding the genetic and biochemical mechanisms leading to disease, this has not resulted in the development of effective therapeutic approaches, amenable of improving clinical course and outcome of these conditions to any significant extent. Therapeutic options for mitochondrial diseases still remain focused on supportive interventions aimed at relieving complications. However, new therapeutic strategies have recently been emerging, some of which have shown potential efficacy at the pre-clinical level. This review will present the state of the art on experimental therapy for mitochondrial disorders. Crown
Copyright © 2015. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Experimental therapy; Mitochondrial disease; Mitochondrial respiratory chain; Mitochondrion; Oxidative phosphorilation

Mesh:

Year:  2015        PMID: 25766847     DOI: 10.1016/j.bbabio.2015.03.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

Review 1.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  Inherited mitochondrial genomic instability and chemical exposures.

Authors:  Sherine S L Chan
Journal:  Toxicology       Date:  2017-07-26       Impact factor: 4.221

3.  The architecture of the mammalian respirasome.

Authors:  Jinke Gu; Meng Wu; Runyu Guo; Kaige Yan; Jianlin Lei; Ning Gao; Maojun Yang
Journal:  Nature       Date:  2016-09-29       Impact factor: 49.962

Review 4.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 5.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

Review 6.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 7.  Mitochondrial Dysfunction in Pulmonary Fibrosis.

Authors:  Sunad Rangarajan; Karen Bernard; Victor J Thannickal
Journal:  Ann Am Thorac Soc       Date:  2017-11

8.  Persistent Mitochondrial Dysfunction Linked to Prolonged Organ Dysfunction in Pediatric Sepsis.

Authors:  Scott L Weiss; Donglan Zhang; Jenny Bush; Kathryn Graham; Jonathan Starr; Florin Tuluc; Sarah Henrickson; Todd Kilbaugh; Clifford S Deutschman; Deborah Murdock; Francis X McGowan; Lance Becker; Douglas C Wallace
Journal:  Crit Care Med       Date:  2019-10       Impact factor: 7.598

9.  Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations.

Authors:  Michelangelo Cao; Marta Donà; M Lucia Valentino; Lucia Valentino; Claudio Semplicini; Alessandra Maresca; Matteo Cassina; Alessandra Torraco; Eva Galletta; Valeria Manfioli; Gianni Sorarù; Valerio Carelli; Roberto Stramare; Enrico Bertini; Rosalba Carrozzo; Leonardo Salviati; Elena Pegoraro
Journal:  Neurogenetics       Date:  2015-11-10       Impact factor: 2.660

10.  Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.

Authors:  Payam A Gammage; Edoardo Gaude; Lindsey Van Haute; Pedro Rebelo-Guiomar; Christopher B Jackson; Joanna Rorbach; Marcin L Pekalski; Alan J Robinson; Marine Charpentier; Jean-Paul Concordet; Christian Frezza; Michal Minczuk
Journal:  Nucleic Acids Res       Date:  2016-07-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.